Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414 · see citing works

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works

In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820 · see citing works

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J., & D, N. A. M. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,849 · see citing works

BioMed Research International

Bellini, M., Charalampidis, S., Herbert, P., Bonatsos, V., Crane, J., Muthusamy, A., Dor, F., & Papalois, V. E. (2022) · BioMed Research International · doi:10.1155/2738 · Cited by 2,431 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Astrocyte scar formation aids central nervous system axon regeneration

Anderson, M. A., Burda, J. E., Ren, Y., Ao, Y., O’Shea, T. M., Kawaguchi, R., Coppola, G., Khakh, B. S., Deming, T. J., & Sofroniew, M. V. (2016) · Nature · doi:10.1038/nature17623 · Cited by 1,851 · see citing works

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 8× · see citing works

ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,426 · see citing works

The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease

Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352 · see citing works

Frontal–subcortical neuronal circuits and clinical neuropsychiatry

Tekin, S., & Cummings, J. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00428-2 · Cited by 1,240 · see citing works

Excitotoxicity and stroke: Identifying novel targets for neuroprotection

Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106 · see citing works

Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes

Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,083 · see citing works

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial

Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60982-9 · Cited by 1,067 · see citing works

4 Histology and Histopathology

(2015) · Thieme eBooks · doi:10.1055/b-0035-108581 · Cited by 1,052 · see citing works

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,045 · see citing works

Neurodegenerative diseases and oxidative stress

Emerit, J., Edeas, M. A., & Bricaire, F. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031 · see citing works

Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature

Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · see citing works

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., & Masurier, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.182 · Cited by 970 · see citing works

Oligodendrocytes: biology and pathology

Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · see citing works

Glia — more than just brain glue

Allen, N. J., & Barres, B. A. (2009) · Nature · doi:10.1038/457675a · Cited by 856 · see citing works

The tripartite synapse: roles for gliotransmission in health and disease

Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852 · see citing works

Microglia: Scapegoat, saboteur, or something else?

Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836 · see citing works

Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity

Arundine, M., & Tymianski, M. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00141-6 · Cited by 827 · see citing works

GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration

Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820 · see citing works

Gene therapy clinical trials worldwide to 2012 – an update

Ginn, S., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 807 · see citing works

Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 725 · see citing works

AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial

LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681 · see citing works

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

Choi-Lundberg, D. L., Lin, Q., Chang, Y., Chiang, Y. L., Hay, C. M., Mohajeri, H. M., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 622 · see citing works

Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease

Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604 · see citing works

Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma

Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592 · see citing works

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583 · see citing works

Microglial cell dysregulation in brain aging and neurodegeneration

von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556 · see citing works

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554 · see citing works

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection

Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., Luo, B., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405186111 · Cited by 527 · see citing works

Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain

Aschauer, D. F., Kreuz, S., & Rumpel, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076310 · Cited by 522 · see citing works

The astrocyte odyssey

Wang, D. D., & Bordey, A. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.015 · Cited by 517 · see citing works

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates

Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., & Samulski, R. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.72 · Cited by 501 · see citing works

Microglia Biology in Health and Disease

Garden, G. A., & Möller, T. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9015-5 · Cited by 494 · see citing works

Nanotechnological advances for the delivery of cns therapeutics.

Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488 · see citing works

GFAP promoter directs astrocyte-specific expression in transgenic mice

Brenner, M., Kisseberth, W., Su, Y., Besnard, F., & Messing, A. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01030.1994 · Cited by 485 · see citing works

Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring <i>in vivo</i>

Dittgen, T., Nimmerjahn, A., Komai, S., Licznerski, P., Waters, J., Margrie, T. W., Helmchen, F., Denk, W., Brecht, M., & Osten, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407976101 · Cited by 485 · see citing works

The life, death, and replacement of oligodendrocytes in the adult CNS

McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 455 · see citing works

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Palfi, S., Gurruchaga, J. M., Ralph, G. S., Lepetit, H., Lavisse, S., Buttery, P. C., Watts, C., Miskin, J., Kelleher, M., Deeley, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61939-x · Cited by 452 · see citing works

Microglia: actively surveying and shaping neuronal circuit structure and function

Wake, H., Moorhouse, A. J., Miyamoto, A., & Nabekura, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.007 · Cited by 448 · see citing works

N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

FAN, M., & Raymond, L. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 410 · see citing works

GFAP promoter elements required for region‐specific and astrocyte‐specific expression

Lee, Y., Messing, A., Su, M., & Brenner, M. (2008) · Glia · doi:10.1002/glia.20622 · Cited by 406 · see citing works

Drug and Gene Delivery to the Brain

Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 405 · see citing works

The benefits and limitations of animal models for translational research in neurodegenerative diseases

Jucker, M. (2010) · Nature Medicine · doi:10.1038/nm.2224 · Cited by 401 · see citing works

Results from a phase I safety trial of <i>hAADC</i> gene therapy for Parkinson disease

Eberling, J. L., Jagust, W. J., Christine, C. W., Starr, P., Larson, P., Bankiewicz, K. S., & Aminoff, M. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312381.29287.ff · Cited by 370 · see citing works

The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia

Ceulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351 · see citing works

Synapse Pathology in Psychiatric and Neurologic Disease

van Spronsen, M., & Hoogenraad, C. C. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0104-8 · Cited by 345 · see citing works

Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders

Bevan, A. K., Duque, S., Foust, K. D., Morales, P. R., Braun, L., Schmelzer, L., Chan, C. M., McCrate, M., Chicoine, L. G., Coley, B. D., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.157 · Cited by 337 · see citing works

The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes

Niranjan, R. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8483-x · Cited by 331 · see citing works

Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential

Buffo, A., Rolando, C., & Ceruti, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321 · see citing works

Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

Kaminski, R., Chen, Y., Fischer, T., Tedaldi, E., Napoli, A., Zhang, Y., Karn, J., Hu, W., & Khalili, K. (2016) · Scientific Reports · doi:10.1038/srep22555 · Cited by 320 · see citing works

Variations in Promoter Activity Reveal a Differential Expression and Physiology of Glutamate Transporters by Glia in the Developing and Mature CNS

Regan, M. R., Huang, Y. H., Kim, Y., Dykes‐Hoberg, M., Jin, L., Watkins, A. M., Bergles, D. E., & Rothstein, J. D. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0790-07.2007 · Cited by 314 · see citing works

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. D. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314 · see citing works

Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease

Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313 · see citing works

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles

Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 311 · see citing works

Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system

Goula, D., Rémy, J.-S., Erbacher, P., Wąsowicz, M., Levi, G., Abdallah, B., & DEMENEIX, B. A. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300635 · Cited by 309 · see citing works

Cold Spring Harbor ProtocolsPreprint

(2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb/ · Cited by 303 · see citing works

Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain

Bartlett, J. S., Samulski, R. J., & McCown, T. J. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.8-1181 · Cited by 301 · see citing works

The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival

Carson, M. J., Cameron Thrash, J., & Walter, B. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.004 · Cited by 299 · see citing works

Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System

Zhang, H., Yang, B., Mu, X., Ahmed, S. S., Su, Q., He, R., Wang, H., Mueller, C., Sena-Esteves, M., Brown, R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.98 · Cited by 291 · see citing works

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

Peel, A., Zolotukhin, S., Schrimsher, G. W., Muzyczka, N., & Reier, P. J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300358 · Cited by 289 · see citing works

Calcium dysregulation in amyotrophic lateral sclerosis

Großkreutz, J., Bosch, L. V. D., & Keller, B. U. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.002 · Cited by 284 · see citing works

Brain-specific expression of an exogenous gene after i.v. administration

Shi, N., Zhang, Y., Zhu, C., Boado, R. J., & Pardridge, W. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221450098 · Cited by 273 · see citing works

Microglia and neuroprotection: From in vitro studies to therapeutic applications

Polazzi, E., & Monti, B. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.009 · Cited by 260 · see citing works

Neuronal changes in normal human aging and Alzheimer's disease.

Uylings, H., & de Brabander, J. D. (2002) · Brain and Cognition · doi:10.1006/brcg.2001.1500 · Cited by 260 · see citing works

Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo

Liu, Y., Miao, Q., Yuan, J., Han, S., Zhang, P., Li, S., Rao, Z., Zhao, W., Ye, Q., Geng, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3975-14.2015 · Cited by 257 · see citing works

Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases

Thomas, C. E., Schiedner, G., Kochanek, S., Castro, M. G., & Lowenstein, P. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120474397 · Cited by 253 · see citing works

Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

Mangraviti, A., Tzeng, S. Y., Kozielski, K., Wang, Y., Jin, Y., Gullotti, D. M., Pedone, M., Buaron, N., Liu, A., Wilson, D. R., et al. (2015) · ACS Nano · doi:10.1021/nn504905q · Cited by 251 · see citing works

Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide

Chui, R. W., & Dorovini‐Zis, K. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-1 · Cited by 250 · see citing works

Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline

Kim, B. O., Liu, Y., Ruan, Y., Xu, Z. C., Schantz, L. D., & He, J. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64304-0 · Cited by 248 · see citing works

Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro–in vivo gap

Joris, F., Manshian, B. B., Peynshaert, K., Smedt, S. C. D., Braeckmans, K., & Soenen, S. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60145e · Cited by 235 · see citing works

Pathology of demyelinating diseases.

Popescu, B. F. G., & Lucchinetti, C. (2012) · Annual Review of Pathology · doi:10.1146/annurev-pathol-011811-132443 · Cited by 228 · see citing works

Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients

Cerullo, V., Pesonen, S. A., Diaconu, I., Escutenaire, S., Arstila, P. T., Ugolini, M., Nokisalmi, P., Raki, M., Laasonen, L., Särkioja, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3567 · Cited by 226 · see citing works

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease

Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223 · see citing works

Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo

Guerrero‐Cazares, H., Tzeng, S. Y., Young, N. P., Abutaleb, A., Quiñones‐Hinojosa, A., & Green, J. J. (2014) · ACS Nano · doi:10.1021/nn501197v · Cited by 221 · see citing works

Mitochondrial dysfunction and its role in motor neuron degeneration in ALS

Manfredi, G., & Xu, Z. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.01.002 · Cited by 215 · see citing works

HIV-1 associated dementia: symptoms and causes

Ghafouri, M., Amini, S., Khalili, K., & Sawaya, B. E. (2006) · Retrovirology · doi:10.1186/1742-4690-3-28 · Cited by 215 · see citing works

Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10

Yang, B., Li, S., Wang, H., Guo, Y., Gessler, D. J., Cao, C., Su, Q., Kramer, J., Zhong, L., Ahmed, S. S., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.68 · Cited by 213 · see citing works

Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles

Andrade-Moraes, C. H., de Oliveira-Pinto, A. V., Castro-Fonseca, E., da Silva, C. G., Guimarães, D. M., Szczupak, D., Parente-Bruno, D. R., Carvalho, L. R. B., Polichiso, L., Valério‐Gomes, B., et al. (2013) · Brain · doi:10.1093/brain/awt273 · Cited by 213 · see citing works

Polymer-Based Gene Delivery: A Current Review on the Uptake and Intracellular Trafficking of Polyplexes

Midoux, P., Breuzard, G., Gomez, J., & Pichon, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786071014 · Cited by 211 · see citing works

Promoters and serotypes: targeting of adeno‐associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo

Шевцова, З. І., Malik, I., Michel, U., Bähr, M., & Kügler, S. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.028159 · Cited by 207 · see citing works

Distinct neuroinflammatory profile in post-mortem human Huntington's disease

Silvestroni, A., Faull, R. L. M., Strand, A. D., & Möller, T. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832e34ee · Cited by 204 · see citing works

Reversible Demyelination, Blood-Brain Barrier Breakdown, and Pronounced Neutrophil Recruitment Induced by Chronic IL-1 Expression in the Brain

Ferrari, C. C., Depino, A. M., Prada, F., Muraro, N. I., Campbell, S. J., Podhajcer, O. L., Perry, V. H., Anthony, D. C., & Pitossi, F. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63438-4 · Cited by 201 · see citing works

Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system

Gardner, J., & Ghorpade, A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10835 · Cited by 199 · see citing works

Targeted Transduction Patterns in the Mouse Brain by Lentivirus Vectors Pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV Envelope Proteins

Watson, D. J., Kobinger, G., Passini, M. A., Wilson, J. M., & Wolfe, J. H. N. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0584 · Cited by 198 · see citing works

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice

Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel-Tigges, J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 197 · see citing works

A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease

Ambrosi, G., Cerri, S., & Blandini, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1149-z · Cited by 195 · see citing works

The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes

Lisi, L., Navarra, P., Feinstein, D., & Russo, C. D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-1 · Cited by 194 · see citing works

Ca2+‐dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β‐treated astrocytes and in a model of A lzheimer's disease

Alberdi, E. M., Wyssenbach, A., Alberdi, M., Sánchez‐Gómez, M. V., Cavaliere, F., Rodriguez, J. J., Verkhratsky, A., & Matute, C. (2013) · Aging Cell · doi:10.1111/acel.12054 · Cited by 188 · see citing works

Expanded Repertoire of AAV Vector Serotypes Mediate Unique Patterns of Transduction in Mouse Brain

Cearley, C. N., Vandenberghe, L. H., Parente, M. K., Carnish, E. R., Wilson, J. M., & Wolfe, J. H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.166 · Cited by 182 · see citing works

Molecular evolution of adeno-associated virus for enhanced glial gene delivery

Koerber, J. T., Klimczak, R., Jang, J.-H., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · Molecular Therapy · doi:10.1038/mt.2009.184 · Cited by 181 · see citing works

Astrogliosis as a therapeutic target for neurodegenerative diseases

Colangelo, A. M., Alberghina, L., & Papa, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.01.014 · Cited by 177 · see citing works

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse

Schuster, D. J., Dykstra, J. A., Riedl, M. S., Kitto, K. F., Belur, L. R., McIvor, R. S., Elde, R. P., Fairbanks, C. A., & Vulchanova, L. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00042 · Cited by 177 · see citing works

Regulation of Oligodendrocyte Development and CNS Myelination by Growth Factors: Prospects for Therapy of Demyelinating Disease

McMorris, F. A., & McKinnon, R. D. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00858.x · Cited by 175 · see citing works

Science, medicine, and the future: Parkinson's disease.

Schapira, A. (1999) · British medical journal · doi:10.1136/bmj.318.7179.311 · Cited by 174 · see citing works

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 174 · see citing works

A High-Efficiency Synthetic Promoter That Drives Transgene Expression Selectively in Noradrenergic Neurons

Hwang, D., Carlezon, W. A., Ole Isacson, A., & Kim, K. (2001) · Human Gene Therapy · doi:10.1089/104303401750476230 · Cited by 172 · see citing works

Stability of Lentiviral Vector-Mediated Transgene Expression in the Brain in the Presence of Systemic Antivector Immune Responses

Abordo‐Adesida, E., Follenzi, A., Barcia, C., Sciascia, S. A., Castro, M. G., Naldini, L., & Lowenstein, P. R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.741 · Cited by 171 · see citing works

Convection-enhanced delivery for the treatment of brain tumors

Debinski, W., & Tatter, S. B. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.99 · Cited by 170 · see citing works

Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy

Bartus, R. T., Weinberg, M. S., & Samulski, R. J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.281 · Cited by 165 · see citing works

Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain

Rungta, R. L., Choi, H. B., Lin, P. J., Ko, R. W., Ashby, D., Nair, J., Manoharan, M., Cullis, P. R., & MacVicar, B. A. (2013) · Molecular Therapy—Nucleic Acids · doi:10.1038/mtna.2013.65 · Cited by 165 · cited 9× · see citing works

Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene Transfer

Bemelmans, A., Horellou, P., Pradier, L., Brunet, I., Colin, P., & Mallet, J. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016393 · Cited by 164 · see citing works

Targeted transgene expression in rat brain using lentiviral vectors

Jakobsson, J., Ericson, C., Swanberg, M., Björk, E., & Lundberg, C. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10719 · Cited by 164 · see citing works

Biomedical Applications of Nanodiamonds in Imaging and Therapy

Perevedentseva, E. V., Lin, Y., Jani, M., & Cheng, C. (2013) · Nanomedicine · doi:10.2217/nnm.13.183 · Cited by 162 · see citing works

Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia

Persidsky, Y., Zheng, J., Miller, D. W., & Gendelman, H. E. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.3.413 · Cited by 161 · see citing works

Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates

Lawlor, P. A., Bland, R. J., Mouravlev, A., Young, D., & During, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.170 · Cited by 161 · see citing works

The biology of CNS remyelination

Franklin, R. J. M., & Kotter, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-1004-6 · Cited by 160 · see citing works

Engineered lentiviral vector targeting astrocytes <i>In vivo</i>

Colin, A., Faideau, M., Dufour, N., Auregan, G., Hassig, R., Andrieu, T., Brouillet, E., Hantraye, P., Bonvento, G., & Déglon, N. (2009) · Glia · doi:10.1002/glia.20795 · Cited by 158 · see citing works

AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction

Samaranch, L., Sebastián, W. S., Kells, A. P., Salegio, E. A., Heller, G., Bringas, J. R., Pivirotto, P., DeArmond, S. J., Forsayeth, J., & Bankiewicz, K. S. (2013) · Molecular Therapy · doi:10.1038/mt.2013.266 · Cited by 157 · see citing works

Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination

Byrnes, A. P., MacLaren, R. E., & Charlton, H. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03045.1996 · Cited by 155 · see citing works

Adeno-associated virus vectors: activity and applications in the CNS

Peel, A. L., & Klein, R. L. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00183-7 · Cited by 155 · see citing works

Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units

Kügler, S., Lingor, P., Schöll, U., Zolotukhin, S., & Bähr, M. (2003) · Virology · doi:10.1016/s0042-6822(03)00162-4 · Cited by 153 · see citing works

Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic Brain

Kim, I., Shin, J., Kim, S.-W., Choi, S., Ahn, J., Han, P., Park, J. S., & Lee, J.-K. (2012) · Molecular Therapy · doi:10.1038/mt.2011.291 · Cited by 150 · see citing works

Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers

Geldenhuys, W. J., Mbimba, T., Bui, T., Harrison, K. A., & Sutariya, V. B. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.589435 · Cited by 144 · see citing works

Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation

Ezcurra, A. L. D. L., Chertoff, M., Ferrari, C. C., Graciarena, M., & Pitossi, F. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.018 · Cited by 140 · see citing works

Viral vectors, tools for gene transfer in the nervous system

Hermens, W. T. J. M. C., & Verhaagen, J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00007-0 · Cited by 140 · see citing works

Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain

Wang, C., Wang, C.-M., Clark, K. R., & Sferra, T. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302011 · Cited by 139 · see citing works

Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier

Tosi, G., Bortot, B., Ruozi, B., Dolcetta, D., Vandelli, M. A., Forni, F., & Severini, G. M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320170006 · Cited by 136 · see citing works

Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study

Pilakka‐Kanthikeel, S., Atluri, V. S. R., Sagar, V., Saxena, S. K., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062241 · Cited by 135 · see citing works

Inhibition of AQP4 expression in astrocytes by RNAi determines alterations in cell morphology, growth, and water transport and induces changes in ischemia related genes

Nicchia, G. P., Frigeri, A., Liuzzi, G. M., & Svelto, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1183fje · Cited by 135 · see citing works

Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter

Zhang, Y., Schlachetzki, F., Zhang, Y.-F., Boado, R. J., & Pardridge, W. M. (2004) · Human Gene Therapy · doi:10.1089/104303404322959498 · Cited by 134 · see citing works

Glial promoter selectivity following AAV-delivery to the immature brain

von Jonquieres, G., Mersmann, N., Klugmann, C. B., Harasta, A. E., Lutz, B., Teahan, O., Housley, G. D., Fröhlich, D., Krämer-Albers, E.-M., & Klugmann, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065646 · Cited by 133 · see citing works

Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain

Kim, I., Lim, C., Kim, J., Nam, H. Y., Nam, K., Kim, S.-W., Park, J., & Lee, J.-K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.011 · Cited by 131 · see citing works

Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain

Rock, R. B., & Peterson, P. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9012-8 · Cited by 130 · see citing works

Trophic Factor Gene Therapy for Parkinson's Disease

Kordower, J. H., & Björklund, A. (2013) · Movement Disorders · doi:10.1002/mds.25344 · Cited by 129 · see citing works

Intramuscular scAAV9-SMN Injection Mediates Widespread Gene Delivery to the Spinal Cord and Decreases Disease Severity in SMA Mice

Benkhelifa‐Ziyyat, S., Besse, A., Roda, M., Duqué, S. I., Astord, S., Carcenac, R., Marais, T., & Barkats, M. (2013) · Molecular Therapy · doi:10.1038/mt.2012.261 · Cited by 128 · see citing works

Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

Hu, X., Zhang, D., Pang, H., Caudle, W. M., Li, Y., Gao, H., Liu, Y., Li, Q., Wilson, B. C., Monte, D. A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7194 · Cited by 125 · see citing works

Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6

Towne, C., Schneider, B. L., Kieran, D., Redmond, D. E., & Aebischer, P. (2010) · Gene Therapy · doi:10.1038/gt.2009.119 · Cited by 124 · see citing works

Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury

Tuinstra, H. M., Avilés, M. O., Shin, S., Holland, S. J., Zelivyanskaya, M. L., Fast, A. G., Ko, S. Y., Margul, D. J., Bartels, A. K., Boehler, R. M., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.002 · Cited by 122 · see citing works

Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity

Sandhu, J. K., Gardaneh, M., Iwasiow, R. M., Lanthier, P. H., Gangaraju, S., Ribecco‐Lutkiewicz, M., Tremblay, R. G., Kiuchi, K., & Sikorska, M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.016 · Cited by 112 · see citing works

Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys

Su, X., Kells, A. P., Huang, E. J., Lee, H. S., Hadaczek, P., Beyer, J., Bringas, J., Pivirotto, P., Penticuff, J., Eberling, J. L., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.103 · Cited by 112 · see citing works

Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease

Merrill, & Scolding, N. J. (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00200.x · Cited by 111 · see citing works

Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg

Kim, J., Choi, J. S., Nam, K., Lee, M., Park, J., & Lee, J.-K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.011 · Cited by 111 · see citing works

Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses

Ciesielska, A., Hadaczek, P., Mittermeyer, G., Zhou, S., Wright, J. F., Bankiewicz, K. S., & Forsayeth, J. (2013) · Molecular Therapy · doi:10.1038/mt.2012.167 · Cited by 108 · see citing works

BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease

Giralt, A., Friedman, H. C., Caneda-Ferrón, B., Urbán, N., Moreno, E., Rubio, N., Blanco, J., Peterson, A. C., Canals, J. M., & Alberch, J. (2010) · Gene Therapy · doi:10.1038/gt.2010.71 · Cited by 106 · see citing works

Accumulation of silver nanoparticles by cultured primary brain astrocytes

Luther, E. M., Koehler, Y., Diendorf, J., Epple, M., & Dringen, R. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/37/375101 · Cited by 106 · see citing works

In vivo delivery of siRNA to the brain by carbosilane dendrimer

Serramía, M. J., Álvarez, S., Fuentes‐Paniagua, E., Clemente, M. I., Sánchez‐Nieves, J., Gómez, R., de la Mata, J., & Muñoz‐Fernández, M. Á. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.042 · Cited by 105 · see citing works

AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy

Rafi, M. A., Rao, H. Z., Passini, M. A., Curtis, M. T., Vanier, M. T., Zaka, M., Luzi, P., Wolfe, J. H. N., & Wenger, D. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.020 · Cited by 105 · see citing works

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA

Prakash, S., Tomaro-Duchesneau, C., Saha, S., Kahouli, & Malhotra, M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43683 · Cited by 104 · see citing works

Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo

Gerdes, C. A., Castro, M. G., & Lowenstein, P. R. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0140 · Cited by 102 · see citing works

Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain

Milligan, E. D., Soderquist, R. G., Malone, S. M., Mahoney, J. H., Hughes, T., Langer, S. J., Sloane, E. M., Maier, S. F., Leinwand, L. A., Watkins, L. R., et al. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x07000488 · Cited by 102 · see citing works

Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan

Weismann, C. M., Ferreira, J. S., Keeler, A. M., Su, Q., Qui, L., Shaffer, S. A., Xu, Z., Gao, G., & Sena‐Esteves, M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv168 · Cited by 102 · see citing works

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Rahim, A. A., Wong, A. M. S., Howe, S. J., Buckley, S. M. K., Acosta-Saltos, A. D., Elston, K. E., Ward, N. J., Philpott, N. J., Cooper, J. D., Anderson, P. N., et al. (2009) · Gene Therapy · doi:10.1038/gt.2008.186 · Cited by 101 · see citing works

Neuron‐specific delivery of nucleic acids mediated by Tet1‐modified poly(ethylenimine)

Park, I., Lasiene, J., Chou, S.-H. S., Horner, P. J., & Pun, S. H. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1062 · Cited by 100 · see citing works

Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors

Cucchiarini, M., Ren, X., Perides, G., & Terwilliger, E. F. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301925 · Cited by 100 · see citing works

Experimental Neurology.

McDowell, F. (1962) · Archives of Neurology · doi:10.1001/archneur.1962.04210060109014 · Cited by 99 · see citing works

Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes

Cisneros, I. E., & Ghorpade, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.011 · Cited by 98 · see citing works

The potential of adeno-associated viral vectors for gene delivery to muscle tissue

Wang, D., Li, Z., Nahid, M. A., & Gao, G. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.871258 · Cited by 97 · see citing works

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease

Zinger, A., Barcia, C., Herrero, M. T., & Guillemin, G. J. (2011) · Parkinson s Disease · doi:10.4061/2011/716859 · Cited by 95 · see citing works

Efficient Gene Therapy for Parkinson's Disease Using Astrocytes as Hosts for Localized Neurotrophic Factor Delivery

Drinkut, A., Tereshchenko, Y., Schulz, J. B., Bähr, M., & Kügler, S. (2011) · Molecular Therapy · doi:10.1038/mt.2011.249 · Cited by 95 · see citing works

Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate HandlingIn Vivo

Escartin, C., Brouillet, E., Gubellini, P., Trioulier, Y., Jacquard, C., Smadja, C., Knott, G. W., Goff, L. K., Déglon, N., Hantraye, P., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0302-06.2006 · Cited by 95 · see citing works

Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system

Rahim, A. A., Wong, A. M. S., Hoefer, K., Buckley, S. M. K., Mattar, C. N. Z., Cheng, S. H., Chan, J. K. Y., Cooper, J. D., & Waddington, S. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-182311 · Cited by 95 · see citing works

A molecular and genetic arsenal for systems neuroscience

Callaway, E. M. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.007 · Cited by 94 · see citing works

MicroRNA‐145 as one negative regulator of astrogliosis

Wang, C., Yang, S., & Tzeng, S. (2014) · Glia · doi:10.1002/glia.22743 · Cited by 93 · see citing works

Adenovirus-Mediated GDNF and CNTF Pretreatment Protects against Striatal Injury Following Transient Middle Cerebral Artery Occlusion in Mice

Hermann, D. M., Kılıç, E., Kügler, S., Isenmann, S., & Bähr, M. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0399 · Cited by 92 · see citing works

Dysregulation of Mitochondrial Calcium Signaling and Superoxide Flashes Cause Mitochondrial Genomic DNA Damage in Huntington Disease

Wang, J., Chen, Q., Wang, X., Wang, Q.-C., Wang, Y., Cheng, H., Guo, C., Sun, Q., Chen, Q., & Tang, T.-S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407726 · Cited by 92 · see citing works

Advances in stroke therapy

Jaffer, H., Morris, V. B., Stewart, D., & Labhasetwar, V. D. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0046-y · Cited by 92 · see citing works

Applications of gene therapy to the CNS

Blömer, U., Naldini, L., Verma, I. M., Trono, D., & Gage, F. H. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1397 · Cited by 88 · see citing works

Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus

Chen, H., McCarty, D., Bruce, A., Suzuki, K., & Suzuki, K. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300547 · Cited by 87 · cited 4× · see citing works

Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease

Lobello, K., Ryan, J. M., Liu, E., Rippon, G. A., & Black, R. S. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/628070 · Cited by 86 · see citing works

Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS

Liu, G., Martins, I. H., Chiorini, J. A., & Davidson, B. L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302554 · Cited by 84 · see citing works

Huntingtin‐lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing

D, N. A. M., & DiFiglia, M. (2014) · Movement Disorders · doi:10.1002/mds.26020 · Cited by 80 · see citing works

Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes

Geppert, M., Hohnholt, M. C., Thiel, K., Nürnberger, S., Grunwald, I., Rezwan, K., & Dringen, R. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/14/145101 · Cited by 80 · see citing works

Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain

Mastorakos, P., Zhang, C., Berry, S., Oh, Y., Lee, S., Eberhart, C. G., Woodworth, G. F., Suk, J. S., & Hanes, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400800 · Cited by 80 · see citing works

Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles

Yurek, D. M., Fletcher, A. M., Smith, G. M., Seroogy, K. B., Ziady, A. G., Molter, J. P., Kowalczyk, T. H., Padegimas, L., & Cooper, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.2 · Cited by 79 · see citing works

Activated astrocytes: a therapeutic target in Alzheimer’s disease?

Fuller, S. L., Münch, G. W., & Steele, M. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.111 · Cited by 77 · see citing works

HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS

Cisneros, I. E., & Ghorpade, A. (2012) · Current HIV Research · doi:10.2174/157016212802138832 · Cited by 74 · see citing works

Rodent models for HIV-associated neurocognitive disorders

Gorantla, S., Poluektova, L. Y., & Gendelman, H. E. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.12.006 · Cited by 74 · see citing works

Application of recombinant adenovirus for in vivo gene delivery to spinal cord

Liu, Y., Himes, B. T., Moul, J., Huang, W., Chow, S. Y., Tessler, A. R., & Fischer, I. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00587-8 · Cited by 72 · see citing works

Oxidative Stress and Therapeutic Approaches in HIV Dementia

Steiner, J. P., Haughey, N. J., Li, W., Venkatesan, A., Anderson, C., Reid, R., Malpica-Llanos, T., Pocernich, C. B., Butterfield, D. A., & Nath, A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2089 · Cited by 71 · see citing works

From the first to the third generation adenoviral vector: What parameters are governing the production yield?

Dormond, E., Perrier, M., & Kamen, A. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.10.003 · Cited by 70 · see citing works

Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery

Rogers, M., & Rush, R. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.026 · Cited by 70 · see citing works

HIV-1 Tat-Induced Microgliosis and Synaptic Damage via Interactions between Peripheral and Central Myeloid Cells

Lu, S., Tremblay, M., King, I. L., Qi, J., Reynolds, H. M., Marker, D. F., Varrone, J. J., Majewska, A. K., Dewhurst, S., & Gelbard, H. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023915 · Cited by 70 · see citing works

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

Jiménez, J. L., Clemente, M. I., Weber, N. D., Sánchez, J. C., Ortega, P., de la Mata, F. J., Gómez, R., García, D., López-Fernández, L. A., & Muñoz‐Fernández, M. Á. (2010) · BioDrugs · doi:10.2165/11538400-000000000-00000 · Cited by 70 · see citing works

Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone

Kwon, E. J., Lasiene, J., Jacobson, B. E., Park, I., Horner, P. J., & Pun, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.086 · Cited by 70 · see citing works

Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival

Xia, C., Yin, H. H., Borlongan, C. V., Chao, J., & Chao, L. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1243 · Cited by 68 · see citing works

AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice

Kiyota, T., Yamamoto, M., Schroder, B., Jacobsen, M. T., Swan, R. J., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.44 · Cited by 68 · see citing works

Gene Therapy Delivery Systems for Enhancing Viral and Nonviral Vectors for Cardiac Diseases: Current Concepts and Future Applications

Katz, M. G., Fargnoli, A. S., Williams, R. D., & Bridges, C. R. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.2517 · Cited by 67 · see citing works

Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration

Homs, J., Ariza, L., Pagès, G., Udina, E., Navarro, X., Chillón, M., & Bosch, A. (2011) · Gene Therapy · doi:10.1038/gt.2011.7 · Cited by 67 · see citing works

Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector

Lai, Z., & Brady, R. O. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10137 · Cited by 67 · see citing works

Generation and Characterization of E1/E2a/E3/E4-Deficient Adenoviral Vectors Encoding Human Factor VIII

Andrews, J. L., Kadan, M. J., Gorziglia, M. I., Kaleko, M., & Connelly, S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0264 · Cited by 66 · see citing works

Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide

Bellini, M. J., Hereñú, C. B., Goya, R. G., & García‐Segura, L. M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-21 · Cited by 66 · see citing works

Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier

Chaturvedi, M., Molino, Y., Sreedhar, B., Khrestchatisky, M., & Kaczmarek, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54750 · Cited by 65 · see citing works

Nanotechnology for CNS delivery of bio-therapeutic agents

Shah, L. K., Yadav, S. K., & Amiji, M. M. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0133-3 · Cited by 64 · see citing works

Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter

Navarro, V., Millecamps, S., Geoffroy, M.-C., Robert, J. J., Valin, A., Mallet, J. J., & Salle, G. L. G. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301008 · Cited by 63 · see citing works

Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice

Shen, F., Fan, Y., Su, H., Zhu, Y., Chen, Y., Liu, W., Young, W. L., & Yang, G. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303048 · Cited by 63 · see citing works

Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism

Segovia, J., Aragón, P. V., & Brenner, M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300776 · Cited by 63 · see citing works

Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain

San Sebastian, W., Samaranch, L., Heller, G., Kells, A. P., Bringas, J., Pivirotto, P., Forsayeth, J., & Bankiewicz, K. S. (2013) · Gene Therapy · doi:10.1038/gt.2013.48 · Cited by 62 · see citing works

Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra

Cannon, J. R., Sew, T., Montero, L. M., Burton, E. A., & Greenamyre, J. T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.016 · Cited by 61 · see citing works

Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice

Gholizadeh, S., Tharmalingam, S., MacAldaz, M. E., & Hampson, D. R. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.076 · Cited by 61 · see citing works

ALDH1A1 is a Marker of Astrocytic Differentiation during Brain Development and Correlates with Better Survival in Glioblastoma Patients

Adam, S. A., Schnell, O., Pöschl, J., Eigenbrod, S., Kretzschmar, H. A., Tonn, J., & Schüller, U. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00592.x · Cited by 60 · see citing works

Polyethylenimine (PEI) in gene therapy: Current status and clinical applications

Casper, J., Schenk, S., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.001 · Cited by 351 · see citing works

New Advances in General Biomedical Applications of PAMAM Dendrimers

de Araújo, R. V., Santos, S. D. S., Ferreira, E. I., & Giarolla, J. (2018) · Molecules · doi:10.3390/molecules23112849 · Cited by 269 · see citing works

Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System

Ojeda-Hernández, D. D., Canales-Aguirre, A. A., Matías‐Guiu, J., Gómez‐Pinedo, U., & Mateos‐Díaz, J. C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00389 · Cited by 172 · see citing works

AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease

Rosenberg, J. B., Kaplitt, M. G., De, B. P., Chen, A., Flagiello, T., Salami, C., Pey, E., Zhao, L., Ricart Arbona, R. J., Monette, S., et al. (2018) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.231 · Cited by 169 · see citing works

Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s Disease

Helmschrodt, C., Höbel, S., Schöniger, S., Bauer, A., Bonicelli, J., Gringmuth, M., Fietz, S. A., Aigner, A. M., Richter, A., & Richter, F. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.08.013 · Cited by 154 · see citing works

Gene therapy for neurological disorders: challenges and recent advancements

Peña, S., Iyengar, R., Eshraghi, R. S., Bencie, N., Mittal, J., Aljohani, A., Mittal, R., & Eshraghi, A. A. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1630415 · Cited by 113 · see citing works

The Promise and Challenge of In Vivo Delivery for Genome Therapeutics

Wilson, R. C., & Gilbert, L. A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00680 · Cited by 92 · see citing works

Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo

Wu, J., Ji, A., Wang, Z., Qiang, G.-H., Qu, Z., Wu, J., & Jiang, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-20505-y · Cited by 91 · see citing works

Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock

Martier, R., & Konstantinova, P. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580179 · Cited by 87 · see citing works

Polyphenols and neurodegenerative diseases: focus on neuronal regeneration

Moradi, S. Z., Jalili, F., Farhadian, N., Joshi, T., Wang, M., Zou, L., Cao, H., Farzaei, M. H., & Xiao, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1865870 · Cited by 62 · see citing works

Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases

Singh, K., Sethi, P., Datta, S., Chaudhary, J. S., kumar, S., V, Jain, D., Gupta, J. K., Kumar, S., Guru, A., & Panda, S. P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102321 · Cited by 62 · see citing works

Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease

Tan, V. T. Y., Mockett, B. G., Ohline, S. M., Parfitt, K. D., Wicky, H. E., Peppercorn, K., Schoderboeck, L., Yahaya, M. F., Tate, W. P., Hughes, S. M., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0348-9 · Cited by 61 · see citing works

Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors

Rice-Boucher, P. J., Cui, X., & Curiel, D. T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.003 · Cited by 60 · see citing works

Non-viral Gene Delivery Methods for Bone and Joints

Gantenbein, B., Tang, S. N., Guerrero, J., Higuita‐Castro, N., Salazar‐Puerta, A. I., Croft, A. S., Gazdhar, A., & Purmessur, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.598466 · Cited by 58 · see citing works

Nanomedicines for the Treatment of CNS Diseases

Reynolds, J. L., & Mahato, R. I. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9725-x · Cited by 49 · see citing works

Advances in the treatment of neuronal ceroid lipofuscinosis

Rosenberg, J. B., Chen, A., Kaminsky, S. M., Crystal, R. G., & Sondhi, D. (2019) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1684258 · Cited by 41 · see citing works

ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression

Robison, A. J., & Nestler, E. J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00723 · Cited by 42 · see citing works

STXBP1 as a therapeutic target for epileptic encephalopathy

Stamberger, H., Weckhuysen, S., & Jonghe, P. D. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1386175 · Cited by 40 · see citing works

Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective

Iqubal, A., Iqubal, M. K., Khan, A. G., Ali, J., Baboota, S., & Haque, S. E. (2020) · Current Gene Therapy · doi:10.2174/1566523220999200716111502 · Cited by 40 · see citing works

Methamphetamine Augments Concurrent Astrocyte Mitochondrial Stress, Oxidative Burden, and Antioxidant Capacity: Tipping the Balance in HIV-Associated Neurodegeneration

Borgmann, K., & Ghorpade, A. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9812-z · Cited by 38 · see citing works

RGD-Modified Nanocarrier-Mediated Targeted Delivery of HIF-1α-AA Plasmid DNA to Cerebrovascular Endothelial Cells for Ischemic Stroke Treatment

Deng, L., Zhang, F., Wu, Y., Luo, J., Mao, X., Long, L., Gou, M., Yang, L., & Deng, D. Y. B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01362 · Cited by 31 · see citing works

CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects

Khan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 33 · see citing works

Wielding the Double‐Edged Sword of Inflammation: Building Biomaterial‐Based Strategies for Immunomodulation in Ischemic Stroke Treatment

Letko-Khait, N., Ho, E., & Shoichet, M. S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010674 · Cited by 27 · see citing works

Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art

Barbullushi, K., Abati, E., Rizzo, F., Bresolin, N., Comi, G. P., & Corti, S. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1533-2 · Cited by 23 · see citing works

Arginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes

Proulx, J. M., Joshi, C., Vijayaraghavalu, S., Saraswathy, M., Labhasetwar, V. D., Ghorpade, A., & Borgmann, K. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250865 · Cited by 21 · see citing works

Designer Extracellular Vesicles Modulate Pro‐Neuronal Cell Responses and Improve Intracranial Retention

Ortega‐Pineda, L., Sunyecz, A., Salazar‐Puerta, A. I., Rincon‐Benavides, M. A., Alzate‐Correa, D., Anaparthi, A. L., Guilfoyle, E., Mezache, L., Struckman, H. L., Duarte‐Sanmiguel, S., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202100805 · Cited by 21 · see citing works

The therapeutic potential of RNA regulation in neurological disorders

Roovers, J., Jonghe, P. D., & Weckhuysen, S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1542429 · Cited by 20 · see citing works

CRISPR in Neurodegenerative Diseases Treatment: An Alternative Approach to Current Therapies

Akbar, A., Haider, R., Agnello, L., Noor, B., Maqsood, N., Atif, F., Ali, W., Ciaccio, M., & Tariq, H. (2025) · Genes · doi:10.3390/genes16080850 · Cited by 20 · see citing works

Acoustically targeted noninvasive gene therapy in large brain volumes

Nouraein, S., Lee, S., Saenz, V. A., Mundo, H. C. D., Yiu, J., & Szablowski, J. O. (2023) · Gene Therapy · doi:10.1038/s41434-023-00421-1 · Cited by 17 · see citing works

Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes

Joshi, C., Raghavan, V., Vijayaraghavalu, S., Gao, Y., Saraswathy, M., Labhasetwar, V. D., & Ghorpade, A. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.009 · Cited by 14 · see citing works

Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury

Boone, D. R., Leek, J. M., Falduto, M. T., Torres, K. E. O., Sell, S. L., Parsley, M. A., Cowart, J. C., Uchida, T., Micci, M., DeWitt, D. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185943 · Cited by 14 · see citing works

Nanoparticle-based Gene Therapy for Neurodegenerative Disorders

Ereej, N., Hameed, H., Khan, M. A., Faheem, S., & Hameed, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575301011240407082559 · Cited by 13 · see citing works

Intranasal gene therapy for the treatment of neurological disorders

Dhas, N. L., Mehta, T. A., Sharma, S., Garkal, A., Yadav, D., Hariharan, K., Shamjetshabam, B., Khot, S. V., Kudarha, R. R., Bangar, P., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00017-5 · Cited by 12 · see citing works

The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment

Thuringer, D., Solary, É., & Garrido, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00246 · Cited by 8 · see citing works

Epigenetic Mechanisms Underlying Pathobiology of Alcohol Use Disorder

Dulman, R. S., Wandling, G. M., & Pandey, S. C. (2020) · Current Pathobiology Reports · doi:10.1007/s40139-020-00210-0 · Cited by 9 · see citing works

Optimizing TDP-43 silencing with siRNA-loaded polymeric nanovectors in neuronal cells for therapeutic applications: balancing knockdown and function

Russo, A., Maiorano, G., Cortese, B., D’Amone, S., Invidia, A., Quattrini, A., Romano, A., Gigli, G., & Palamà, I. E. (2024) · Nanoscale · doi:10.1039/d4nr03159h · Cited by 7 · see citing works

Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents

Abdallah, K., Nadeau, F., Bergeron, F., Blouin, S., Blais, V., Bradbury, K. M., Lavoie, C. L., Parent, J., & Gendron, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-25626-y · Cited by 8 · see citing works

Cartilage Repair and Regeneration

Zorzi, A. R., & de Miranda, J. B. (2018) · InTech eBooks · doi:10.5772/67903 · Cited by 7 · see citing works

Translational Approach using Advanced Therapy Medicinal Products for Huntington's Disease

Mousavi, M. A., Rezaei, M., Pourhamzeh, M., Salari, M., Hossein‐Khannazer, N., Shpichka, A. I., Nabavi, S. M., Timashev, P. S., & Vosough, M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328300166240510071548 · Cited by 6 · see citing works

Breaking Boundaries in the Brain—Advances in Editing Tools for Neurogenetic Disorders

Coorey, B., & Gold, W. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.623519 · Cited by 7 · see citing works

Genome engineering for CNS injury and disease

Pardieck, J., & Sakiyama‐Elbert, S. E. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.001 · Cited by 6 · see citing works

Viruses: Friends and Foes

Rudd, P. A., & Herrero, L. J. (2018) · InTech eBooks · doi:10.5772/intechopen.71071 · Cited by 4 · see citing works

Effective Gene Transfer with Non‐Viral Vectors

Mavi, A. K., Gaur, S., Kumar, N., Shrivastav, A. K., Bhattacharya, S., Belemkar, S., Maru, S., & Kumar, D. (2023) · doi:10.1002/9781394175635.ch7 · Cited by 3 · see citing works

Calcium Imaging in Vivo: How to Correctly Select and Apply Fiber Optic Photometric Indicators

Wu, L., Sun, W., Huang, L., Sun, L., Dou, J., & Lu, G. (2025) · Organogenesis · doi:10.1080/15476278.2025.2489667 · Cited by 2 · see citing works

Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector

Lockowandt, M., Günther, D. M., Quintino, L., Breger, L. S., Isaksson, C., & Lundberg, C. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108542 · Cited by 2 · see citing works

Acoustically Targeted Noninvasive Gene Therapy in Large Brain RegionsPreprint

Nouraein, S., Lee, S., Saenz, V. A., Mundo, H. C. D., Yiu, J., & Szablowski, J. O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.524626 · Cited by 2 · see citing works

Electrospun chitosan as a drug delivery system

Parhi, R., Jena, B. R., Ratha, B. N., & Swain, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29066-4.00025-1 · Cited by 1 · see citing works

Efficient Modified-mRNA Transfection in Neural Stem Cells

Khayamabed, R., Rezaie, N., Poorgolizadeh, E., Moghadam, F. H., Dorminani, K., & Nasr‐Esfahani, M. H. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.27.1.5 · Cited by 1 · see citing works

Targeted Therapy for Neurological Disorders Using Nanomaterial-Based Drug Delivery Vehicle

Sharma, M., Gupta, T., Gupta, N., Rawat, R., Badoniya, N., Pandey, E., & Sharma, S. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0308-1_7

Avanços na Terapia Gênica para Doenças Neurológicas: Promessas e Desafios

Neto, R. O. C., Borges, C. R. M. D. C., Castro, A. D. O., Cordeiro, B. P., Hernandez, R. T., Ferreira, Y. L., Neto, C. M. D. S., de Souza, G. S., Amaral, H. E. F., MOURA, L. S. D. A., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n9p381-399

Vanishing white matter

van der Knaap, M. S., & Abbink, T. E. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00016-9

Gene therapy for neurodegenration

Koduru, T. S., Osmani, R. A. M., & Madhuchandra, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00027-1

The chloride/potassium co-transporter KCC2 in synaptic plasticity, hippocampal rhythmogenesis and memory

Simonnet, C. (2019) · doi:10.70675/dcc67be7z8c6dz47b5z92e8z4d75367bfd48

Recent advances and clinical prospects of non-viral brain-targeted gene delivery systems

Wang, S., Xu, L.-L., Ma, F., Xu, M., Chen, G., Wang, D., Wu, X., Wang, P., Yu, J., & Shi, L. (2025) · Applied Physics Reviews · doi:10.1063/5.0255745 · Cited by 4 · see citing works

Viral vectors for gene delivery to the central nervous system

Ingusci, S., Hall, B. L., Goins, W. F., Cohen, J. B., & Glorioso, J. C. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00001-0 · Cited by 5 · see citing works

The gene therapy of central nervous system disorders

Wang, Z. (2002) · Basic medical sciences and clinics · Cited by 2 · see citing works

Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part II: Vector Systems and Delivery Methodologies for Gene Therapy of the Central Nervous System

Zloković, B. V., & Apuzzo, M. L. J. (1997) · Neurosurgery · doi:10.1097/00006123-199704000-00028 · Cited by 116 · see citing works

The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System

Piguet, F., Saint-Denis, T. D., Audouard, E., Beccaria, K., André, A., Wurtz, G., Schatz, R., Alves, S., Sevin, C., Zérah, M., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.105 · Cited by 44 · see citing works